FDA Inspection 1064666 — Lawrence Levinson, M.D.

Lawrence Levinson, M.D. — FEI 3010794556

The FDA completed an inspection of Lawrence Levinson, M.D. on Sep 6, 2018 in Altoona, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 6, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Altoona, PA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate